For people living with type 2 diabetes, blood sugar management has traditionally meant finger-prick tests a few times a day and long gaps of guesswork in between. Continuous glucose monitors are changing that picture. Worn on the arm or abdomen, these small sensors read glucose levels every few minutes, day and night, and the evidence now suggests they help patients with type 2 diabetes spend roughly five more hours a day inside a healthy blood-sugar range — time that used to be spent drifting too high or dipping too low.
The finding matters because time in range has become one of the most meaningful measures in diabetes care. Every extra hour spent at safe glucose levels is an hour in which the slow damage associated with diabetes — to eyes, kidneys, nerves and blood vessels — is less likely to accumulate. Readers following our health coverage will know that complications, not the diagnosis itself, are what most patients fear.
What the Sensors Actually Show
A continuous glucose monitor, or CGM, uses a tiny filament under the skin to measure glucose in the fluid between cells. Readings stream to a phone or receiver, complete with trend arrows showing whether levels are rising, falling or holding steady. That context is something a finger-prick test can never provide: instead of a single number, patients see the effect of a meal, a walk or a stressful meeting within the hour it happens.
Guidance from the Centers for Disease Control and Prevention stresses that regular monitoring is central to managing diabetes well, and clinicians say the feedback loop is what drives the improvement. When people can see a breakfast spike in real time, they adjust the next breakfast. Behaviour changes that once took months of appointments can happen in a fortnight of wearing a sensor.
Why Five Hours Is a Big Number
Five additional hours a day in range compounds quickly. Over a year it amounts to more than 1,800 hours — roughly 75 full days — spent at glucose levels associated with lower complication risk. Studies of CGM use in type 2 diabetes have also linked the devices to reductions in HbA1c, the three-month average blood-sugar measure, and to fewer severe low-blood-sugar episodes, which are a particular danger for people using insulin.
There is a psychological dividend too. Many patients describe the constant mental arithmetic of diabetes — estimating, worrying, correcting — as exhausting. A sensor that quietly watches in the background, and alarms only when action is needed, returns some of that headspace. Our homepage regularly covers how small, sustained changes outperform dramatic short-lived ones in chronic disease, and CGM use fits that pattern exactly.
The Barriers: Cost, Access and Habit
None of this is automatic. Sensors are consumables, replaced every 10 to 14 days, and out-of-pocket costs can be significant where insurance coverage lags behind the evidence. Coverage rules were written when CGMs were reserved mainly for type 1 diabetes, and many type 2 patients — especially those not using insulin — still face prior-authorisation hurdles or outright denials.
There are practical frictions as well. Adhesives irritate some skin, readings can lag behind blood glucose during rapid changes, and the sheer volume of data overwhelms a minority of users. Diabetes educators say the best results come when the first weeks of data are reviewed with a clinician, so alarms and targets are set sensibly rather than left at factory defaults.
Who Should Ask About One?
The American Diabetes Association recommends CGMs for people with type 2 diabetes who use insulin, and the case is strengthening for others whose control remains poor despite medication and effort. Anyone whose HbA1c stays above target, who experiences unexplained lows, or who simply cannot face more finger-pricks is a reasonable candidate for a conversation with their care team.
The direction of travel is clear. Sensors are getting smaller, cheaper and easier to start, and the five-hours-a-day figure explains why clinicians increasingly treat continuous monitoring not as a gadget for the few, but as a standard tool for the many. For a condition managed in minutes and meals rather than in hospital wards, seeing the full picture turns out to be half the treatment.
